Hologic To Delay Digital Mammography Launch Pending Selenia Approval
This article was originally published in The Gray Sheet
Executive Summary
Hologic's Selenia digital mammography system for breast cancer screening and detection should receive FDA market go-ahead by year-end, the firm claims. A PMA supplement for the second-generation digital mammography system, which incorporates proprietary amorphous selenium DirectRay technology, will be filed shortly